GARRETT MARVIN J 4

Accession 0001181431-12-031531

CIK 0000930553other

View on SEC.gov Company Profile

Filed

May 20, 8:00 PM ET

Accepted

May 21, 8:01 PM ET

Size

39.0 KB

Accession

0001181431-12-031531

Insider Transaction Report

Form 4

Period: 2012-05-17

ISTA PHARMACEUTICALS INCISTA

GARRETT MARVIN J

Vice President, QC, Compliance

Transactions

Tax Payment
Common Stock
2012-05-17$9.06/sh−20,338$184,262→ 69,681 total
Exercise/Conversion
Common Stock
2012-05-17$6.82/sh+2,613$17,821→ 104,071 total
Tax Payment
Common Stock
2012-05-17$9.06/sh−1,967$17,821→ 102,104 total
Exercise/Conversion
Common Stock
2012-05-17$3.49/sh+87,303$304,687→ 189,407 total
Tax Payment
Common Stock
2012-05-17$9.06/sh−33,630$304,688→ 155,777 total
Exercise/Conversion
Incentive Stock Option (right to buy)
2012-05-17$9.06/sh−14,878$134,795→ 7,875 total
Exercise: $1.04From: 2009-03-03Exp: 2019-02-03→ Common Stock (14,878 underlying)
Exercise/Conversion
Incentive Stock Option (right to buy)
2012-05-17$9.06/sh−87,303$790,965→ 0 total
Exercise: $3.49From: 2002-12-16Exp: 2012-12-16→ Common Stock (87,303 underlying)
Exercise/Conversion
Incentive Stock Option (right to buy)
2012-05-17$9.60/sh−12,329$118,358→ 18,375 total
Exercise: $3.63From: 2010-03-02Exp: 2020-02-02→ Common Stock (12,329 underlying)
Exercise/Conversion
Incentive Stock Option (right to buy)
2012-05-17$9.06/sh−17,518$158,713→ 0 total
Exercise: $4.46From: 2008-03-08Exp: 2018-02-08→ Common Stock (17,518 underlying)
Exercise/Conversion
Incentive Stock Option (right to buy)
2012-05-17$9.06/sh−27,218$246,595→ 0 total
Exercise: $6.77From: 2006-03-16Exp: 2016-02-16→ Common Stock (27,218 underlying)
Exercise/Conversion
Incentive Stock Option (right to buy)
2012-05-17$9.06/sh−2,613$23,674→ 25,724 total
Exercise: $6.82From: 2011-03-07Exp: 2021-02-07→ Common Stock (2,613 underlying)
Tax Payment
Common Stock
2012-05-17$9.06/sh−4,940$44,756→ 101,458 total
Exercise/Conversion
Incentive Stock Option (right to buy)
2012-05-17$9.06/sh−12,919$117,046→ 0 total
Exercise: $7.43From: 2007-03-02Exp: 2017-02-02→ Common Stock (12,919 underlying)
Exercise/Conversion
Common Stock
2012-05-17$6.77/sh+27,218$184,266→ 90,019 total
Exercise/Conversion
Common Stock
2012-05-17$7.43/sh+12,919$95,988→ 82,600 total
Tax Payment
Common Stock
2012-05-17$9.06/sh−10,595$95,991→ 72,005 total
Exercise/Conversion
Common Stock
2012-05-17$4.46/sh+17,518$78,130→ 89,523 total
Tax Payment
Common Stock
2012-05-17$9.06/sh−8,624$78,133→ 80,899 total
Exercise/Conversion
Common Stock
2012-05-17$1.04/sh+14,878$15,473→ 95,777 total
Tax Payment
Common Stock
2012-05-17$9.06/sh−1,708$15,474→ 94,069 total
Exercise/Conversion
Common Stock
2012-05-17$3.63/sh+12,329$44,754→ 106,398 total

Footnotes (1)

[F1]Mr. Garrett exercised options for 174,778 of Issuer's shares under his Employee Stock Option (as shown in Table II of this Form 4). Of that amount, Mr. Garrett elected to have the Issuer withhold 81,802 shares to cover the exercise price in connection with the exercise of his Employee Stock Option (as shown in Table II of the Form 4). Mr. Garrett continues to hold the net remaining amount of 92,976 shares.

Documents

1 file

4
rrd346077.xmlPrimary
FORM 4

Issuer

ISTA PHARMACEUTICALS INC

CIK 0000930553

→

Entity typeother

Related Parties

filerCIK 0001216987

Filing Metadata

Form type: 4
Filed: May 20, 8:00 PM ET
Accepted: May 21, 8:01 PM ET
Size: 39.0 KB

View on SEC.gov